Eph and ephrin interactions in bone

Advances in Experimental Medicine and Biology

Volumn 658, Issue , 2010, Pages 95-103

  Matsuo, Koichi ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Bone remodeling; Eph; Ephrin; Osteoclast

Indexed keywords

COLLAGENASE 3; EPHRIN; EPHRIN B2; EPHRIN B4; EPHRIN RECEPTOR; EPHRIN RECEPTOR A1; EPHRIN RECEPTOR A2; EPHRIN RECEPTOR A3; EPHRIN RECEPTOR A4; EPHRIN RECEPTOR A5; EPHRIN RECEPTOR A6; EPHRIN RECEPTOR A7; EPHRIN RECEPTOR A8; EPHRIN RECEPTOR A9; EPHRIN RECEPTOR B1; EPHRIN RECEPTOR B2; EPHRIN RECEPTOR B3; EPHRIN RECEPTOR B4; EPHRIN RECEPTOR B6; GELATINASE B; INTERSTITIAL COLLAGENASE; UNCLASSIFIED DRUG;

ADIPOCYTE; BONE METABOLISM; BONE REMODELING; CARTILAGE CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL INTERACTION; CONFERENCE PAPER; FIBROBLAST; MONOCYTE; MYOBLAST; NONHUMAN; OSSIFICATION; OSTEOARTHRITIS; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; BONE AND BONES; EPHRINS; HUMANS; MICE; MODELS, BIOLOGICAL; OSTEOBLASTS; OSTEOCLASTS; PROTEIN BINDING; RECEPTORS, EPH FAMILY;

EID: 78649960769     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-1050-9_10     Document Type: Conference Paper

References (28)

1. Allan, E. H., Hausler, K. D., Wei, T., Gooi, J. H., Quinn, J. M., Crimeen-Irwin, B., Pompolo, S. et al. (2008). EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblasts. J Bone Miner Res, 23, 1170-1181. (Pubitemid 352040173)
2. Compagni, A., Logan, M., Klein, R., & Adams, R. H. (2003). Control of skeletal patterning by ephrinB1-EphB interactions. Dev Cell, 5, 217-230. (Pubitemid 37006467)
3. Davy, A., Bush, J. O., & Soriano, P. (2006). Inhibition of gap junction communication at ectopic Eph/ephrin boundaries underlies craniofrontonasal syndrome. PLoS Biol, 4, e315.
4. Edwards, C. M., & Mundy, G. R. (2008). Eph receptors and ephrin signaling pathways: a role in bone homeostasis. Int J Med Sci, 5, 263-272.
5. Eph Nomenclature Committee (1997). Unified nomenclature for Eph family receptors and their ligands, the ephrins. Eph Nomenclature Committee. Cell, 90, 403-404.
6. Fuller, K., Wong, B., Fox, S., Choi, Y., & Chambers, T. J. (1998). TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med, 188, 997-1001. (Pubitemid 28433427)
7. Harmey, D., Stenbeck, G., Nobes, C. D., Lax, A. J., & Grigoriadis, A. E. (2004). Regulation of osteoblast differentiation by Pasteurella multocida toxin (PMT): a role for Rho GTPase in bone formation. J Bone Miner Res, 19, 661-670. (Pubitemid 41071227)
8. Hattner, R., Epker, B. N., & Frost, H. M. (1965). Suggested sequential mode of control of changes in cell behaviour in adult bone remodelling. Nature, 206, 489-490.
9. Irie, N., Takada, Y., Watanabe, Y., Matsuzaki, Y., Naruse, C., Asano, M., Iwakura, Y. Sudha, T., & Matsuo, K. (2009). Bidirectional signaling through ephrinA2-EphA2 enhances osteoclastogenesis and suppresses osteoblastogenesis. J Biol Chem, 284, 14637-14644.
10. Ishii, M., Egen, J. G., Klauschen, F., Meier-Schellersheim, M., Saeki, Y., Vacher, J., Proia, R.L., & Germain, R. N. (2009). Sphingosine-1- phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature, 458, 524-528.
11. Kim, I., Ryu, Y. S., Kwak, H. J., Ahn, S. Y., Oh, J. L., Yancopoulos, G. D. et al. (2002). EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells. Faseb J, 16, 1126-1128.
12. Kim, Y., Sato, K., Asagiri, M., Morita, I., Soma, K., & Takayanagi, H. (2005). Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis. J Biol Chem, 280, 32905-32913. (Pubitemid 41368340)
13. Koga, T., Inui, M., Inoue, K., Kim, S., Suematsu, A., Kobayashi, E. et al. (2004). Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature, 428, 758-763. (Pubitemid 38508286)
14. Korff, T., Braun, J., Pfaff, D., Augustin, H. G., & Hecker,M. (2008). Role of ephrinB2 expression in endothelial cells during arteriogenesis: impact on smooth muscle cell migration and monocyte recruitment. Blood, 112, 73-81.
15. Kuroda, C., Kubota, S., Kawata, K., Aoyama, E., Sumiyoshi, K., Oka, M. et al. (2008). Distribution, gene expression, and functional role of EphA4 during ossification. Biochem Biophys Res Commun, 374, 22-27.
16. Kwan Tat, S., Pelletier, J. P., Amiable, N., Boileau, C., Lajeunesse, D., Duval, N., & Martel-Pelletier, J. (2008). Activation of the receptor EphB4 by its specific ligand ephrin B2 in human osteoarthritic subchondral bone osteoblasts. Arthritis Rheum, 58, 3820-3830.
17. Lacey, D. L., Timms, E., Tan, H. L., Kelley, M. J., Dunstan, C. R., Burgess, T. et al. (1998). Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell, 93, 165-176. (Pubitemid 28180851)
18. Matsuo, K., & Irie, N. (2008). Osteoclast-osteoblast communication. Arch Biochem Biophys, 473, 201-209.
19. Matsuo, K., & Ray, N. (2004). Osteoclasts, mononuclear phagocytes, and c-Fos: new insight into osteoimmunology. Keio J Med, 53, 78-84. (Pubitemid 38899740)
20. McBeath, R., Pirone, D. M., Nelson, C. M., Bhadriraju, K., & Chen, C. S. (2004). Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell, 6, 483-495. (Pubitemid 38456178)
21. Mundy, G. R., & Elefteriou, F. (2006). Boning up on ephrin signaling. Cell, 126, 441-443. (Pubitemid 44163612)
22. Pasquale, E. B. (2008). Eph-ephrin bidirectional signaling in physiology and disease. Cell, 133, 38-52. (Pubitemid 351442996)
23. Pelletier, J. P., Boileau, C., Brunet, J., Boily, M., Lajeunesse, D., Reboul, P., Laufer, S., & Martel-Pelletier, J. (2004). The inhibition of subchondral bone resorption in the early phase of experimental dog osteoarthritis by licofelone is associated with a reduction in the synthesis of MMP-13 and cathepsin K. Bone, 34, 527-538. (Pubitemid 38314917)
24. Pfaff, D., Heroult, M., Riedel, M., Reiss, Y., Kirmse, R., Ludwig, T., Korff, T., Hecker, M., & Augustin, H. G. (2008). Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes. J Cell Sci, 121, 3842-3850.
25. Takahashi, N., Akatsu, T., Udagawa, N., Sasaki, T., Yamaguchi, A., Moseley, J.M., Martin, T. J., & Suda, T. (1988). Osteoblastic cells are involved in osteoclast formation. Endocrinology, 123, 2600-2602.
26. Twigg, S. R., Kan, R., Babbs, C., Bochukova, E. G., Robertson, S. P.,Wall, S. A., Morriss-Kay, G. M., &Wilkie, A. O. (2004). Mutations of ephrin-B1 (EFNB1), a marker of tissue boundary formation, cause craniofrontonasal syndrome. Proc Natl Acad Sci U S A, 101, 8652-8657. (Pubitemid 38745826)
27. Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S. et al. (1998). Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesisinhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A, 95, 3597-3602.
28. Zhao, C., Irie, N., Takada, Y., Shimoda, K., Miyamoto, T., Nishiwaki, T., Suda, T., & Matsuo, K.(2006). Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab, 4,111-121. (Pubitemid 44138718)